These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 25822860)

  • 1. Clinical, metabolic, and psychological characteristics in patients with gastroesophageal reflux disease overlap with irritable bowel syndrome.
    Hsu CS; Liu TT; Wen SH; Wang CC; Yi CH; Chen JH; Lei WY; Orr WC; Fabio P; Chen CL
    Eur J Gastroenterol Hepatol; 2015 May; 27(5):516-22. PubMed ID: 25822860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of concomitant dyspepsia and irritable bowel syndrome on symptom burden in patients with gastroesophageal reflux disease.
    Lei WY; Chang WC; Wen SH; Wong MW; Hung JS; Yi CH; Liu TT; Hsu CS; Orr WC; Vaezi MF; Pace F; Hsieh TC; Chen CL
    J Formos Med Assoc; 2019 Apr; 118(4):797-806. PubMed ID: 30584006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overlap of Dyspepsia in Patients with Gastroesophageal Reflux Disease: Impact of Clinical, Metabolic, and Psychosocial Characteristics.
    Hsu CS; Wen SH; Hung JS; Liu TT; Yi CH; Lei WY; Pace F; Chen CL
    Dig Dis Sci; 2017 Apr; 62(4):994-1001. PubMed ID: 28116594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overlap of symptoms of gastroesophageal reflux disease, dyspepsia and irritable bowel syndrome in the general population.
    Rasmussen S; Jensen TH; Henriksen SL; Haastrup PF; Larsen PV; Søndergaard J; Jarbøl DE
    Scand J Gastroenterol; 2015 Feb; 50(2):162-9. PubMed ID: 25525975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and risk factors for overlaps between gastroesophageal reflux disease, dyspepsia, and irritable bowel syndrome: a population-based study.
    Lee SY; Lee KJ; Kim SJ; Cho SW
    Digestion; 2009; 79(3):196-201. PubMed ID: 19342860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitant functional dyspepsia and irritable bowel syndrome decrease health-related quality of life in gastroesophageal reflux disease.
    De Vries DR; Van Herwaarden MA; Baron A; Smout AJ; Samsom M
    Scand J Gastroenterol; 2007 Aug; 42(8):951-6. PubMed ID: 17613924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The lifetime prevalence of anxiety disorders among patients with irritable bowel syndrome.
    Grzesiak M; Beszłej JA; Mulak A; Szechiński M; Szewczuk-Bogusławska M; Waszczuk E; Kantorska M; Frydecka D
    Adv Clin Exp Med; 2014; 23(6):987-92. PubMed ID: 25618127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overlapping gastroesophageal reflux disease and irritable bowel syndrome: increased dysfunctional symptoms.
    Yarandi SS; Nasseri-Moghaddam S; Mostajabi P; Malekzadeh R
    World J Gastroenterol; 2010 Mar; 16(10):1232-8. PubMed ID: 20222167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overlap of gastro-oesophageal reflux disease and irritable bowel syndrome: prevalence and risk factors in the general population.
    Jung HK; Halder S; McNally M; Locke GR; Schleck CD; Zinsmeister AR; Talley NJ
    Aliment Pharmacol Ther; 2007 Aug; 26(3):453-61. PubMed ID: 17635380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cigarette smoking and its association with overlapping gastroesophageal reflux disease, functional dyspepsia, or irritable bowel syndrome.
    Fujiwara Y; Kubo M; Kohata Y; Machida H; Okazaki H; Yamagami H; Tanigawa T; Watanabe K; Watanabe T; Tominaga K; Arakawa T
    Intern Med; 2011; 50(21):2443-7. PubMed ID: 22041340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomised clinical trial: sustained response to PPI treatment of symptoms resembling functional dyspepsia and irritable bowel syndrome in patients suffering from an overlap with erosive gastro-oesophageal reflux disease.
    Mönnikes H; Schwan T; van Rensburg C; Straszak A; Theek C; Sander P; Lühmann R
    Aliment Pharmacol Ther; 2012 Jun; 35(11):1279-89. PubMed ID: 22486552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-rated health and functional capacity in individuals reporting overlapping symptoms of gastroesophageal reflux disease, functional dyspepsia and irritable bowel syndrome - a population based study.
    Jarbøl DE; Rasmussen S; Balasubramaniam K; Elnegaard S; Haastrup PF
    BMC Gastroenterol; 2017 May; 17(1):65. PubMed ID: 28521729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of coexisting irritable bowel syndrome and non-erosive reflux disease on postprandial abdominal fullness and sleep disorders in functional dyspepsia.
    Futagami S; Yamawaki H; Shimpuku M; Izumi N; Wakabayashi T; Kodaka Y; Nagoya H; Shindo T; Kawagoe T; Sakamoto C
    J Nippon Med Sch; 2013; 80(5):362-70. PubMed ID: 24189354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastroesophageal reflux disease (GERD) and irritable bowel syndrome (IBS)--is it one disease or an overlap of two disorders?
    Gasiorowska A; Poh CH; Fass R
    Dig Dis Sci; 2009 Sep; 54(9):1829-34. PubMed ID: 19082721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional Heartburn Overlaps With Irritable Bowel Syndrome More Often than GERD.
    de Bortoli N; Frazzoni L; Savarino EV; Frazzoni M; Martinucci I; Jania A; Tolone S; Scagliarini M; Bellini M; Marabotto E; Furnari M; Bodini G; Russo S; Bertani L; Natali V; Fuccio L; Savarino V; Blandizzi C; Marchi S
    Am J Gastroenterol; 2016 Dec; 111(12):1711-1717. PubMed ID: 27644732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of co-morbid IBS and psychological distress on outcomes and quality of life following PPI therapy in patients with gastro-oesophageal reflux disease.
    Nojkov B; Rubenstein JH; Adlis SA; Shaw MJ; Saad R; Rai J; Weinman B; Chey WD
    Aliment Pharmacol Ther; 2008 Mar; 27(6):473-82. PubMed ID: 18194508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of overlaps between GERD, FD and IBS and impact on health-related quality of life.
    Kaji M; Fujiwara Y; Shiba M; Kohata Y; Yamagami H; Tanigawa T; Watanabe K; Watanabe T; Tominaga K; Arakawa T
    J Gastroenterol Hepatol; 2010 Jun; 25(6):1151-6. PubMed ID: 20594232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Irritable bowel syndrome, gastro-oesophageal reflux disease and dyspepsia: overlap analysis using loglinear models.
    Pourhoseingholi A; Vahedi M; Pourhoseingholi MA; Ashtari S; Moghimi-Dehkordi B; Safaee A; Zali MR
    Arab J Gastroenterol; 2012 Mar; 13(1):20-3. PubMed ID: 22560820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Comorbid Irritable Bowel Syndrome on Treatment Outcome in Non-Erosive Reflux Disease on Long-Term Proton Pump Inhibitor in Japan.
    Funaki Y; Kaneko H; Kawamura Y; Yoshimine T; Tamura Y; Izawa S; Ebi M; Ogasawara N; Sasaki M; Kasugai K
    Digestion; 2017; 96(1):39-45. PubMed ID: 28641289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irritable bowel syndrome subtypes: Clinical and psychological features, body mass index and comorbidities.
    Kibune Nagasako C; Garcia Montes C; Silva Lorena SL; Mesquita MA
    Rev Esp Enferm Dig; 2016 Feb; 108(2):59-64. PubMed ID: 26838486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.